The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 study.

Hande KR, Hagey A, Berlin J, Cai Y, Meek K, Kobayashi H, Lockhart AC, Medina D, Sosman J, Gordon GB, Rothenberg ML
Clin Cancer Res. 2006 12 (9): 2834-40

PMID: 16675578 · DOI:10.1158/1078-0432.CCR-05-2159

MeSH Terms (13)

Administration, Oral Adult Aged Biological Availability Cell Division Drug Administration Schedule Female Humans Male Middle Aged Neoplasms Safety Sulfonamides

Connections (3)

This publication is referenced by other Labnodes entities: